Finally, given the APOE-ε4 gene is linked to increased AD risk and cardiometabolic dysfunction, we hypothesized that ε4 carriers would demonstrate stronger associations between blood pressure and all biomarkers evaluated (GFAP, NfL, pTau181, Aβ42/40) [28]. The gene discussed is APOE; the disease is Alzheimer disease.